Instill one drop of cyclosporine ophthalmic emulsion, 0.05% twice a day in each eye approximately 12 hours apart.
drug label
Restasis prescribing information
Need to report a Restasis issue?
ONLINE FORMReport adverse event
Learn More
You can report a Restasis adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
people also ask
Restasis FAQs
How is the dosage of Restasis?Restasis is available in 2 dosages, including 0.05% Susp and 0.05% Susp
What does Restasis treat?Restasis treats Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus, Myasthenia Gravis and Psoriasis
What is Restasis made of?Restasis contains cyclosporine which is a Calcineurin Inhibitor Immunosuppressant
How Is Restasis Administered?Restasis is administered as a Ophthalmic
What Are The Restasis Mechanism Of Action?Restasis mechanism of action is Calcineurin Inhibitors, Cytochrome P450 3A4 Inhibitors or P-Glycoprotein Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
Can't find what you're looking for?
Our trained staff can help you:
Please note:
Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.